A study of monoamine neuronal systems of schizophrenic patients: Using forensic autopsy brains

Legal Medicine

Volumn 11, Issue SUPPL. 1, 2009, Pages

  Ikemoto, Keiko ^a   Nishi, Katsuji ^b   Kunii, Yasuto ^a   Wada, Akira ^a   Yang, Qiaohui ^a   Takase, Izumi ^b   Nishimura, Akiyoshi ^c   Niwa, Shin ichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Aromatic l amino acid decarboxylase; Brain bank; Dopamine; Immunohistochemistry; Schizophrenia; Tyrosine hydroxylase

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; PHENYLETHANOLAMINE N METHYLTRANSFERASE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; AUTOPSY; BRAIN STEM; CATECHOLAMINE NERVE CELL; CELL STRUCTURE; CELL SUBPOPULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONOAMINE NERVE CELL; NEURAL STEM CELL; ORGAN PRESERVATION; SCHIZOPHRENIA; TISSUE STRUCTURE;

AROMATIC-L-AMINO-ACID DECARBOXYLASES; BRAIN; CASE-CONTROL STUDIES; EPIGENESIS, GENETIC; FORENSIC PATHOLOGY; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; SCHIZOPHRENIA; STEM CELLS; TISSUE BANKS; TYROSINE 3-MONOOXYGENASE;

EID: 65749090440     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.legalmed.2009.02.010     Document Type: Article

References (47)

1. Nishimura A., Ikemoto K., Satoh K., Yamamoto Y., Rand S., Brinkmann B., et al. The carbohydrate deposits detected by histochemical methods in the molecular layer of the dentate gyrus in the hippocampal formation of patients with schizophrenia, Down's syndrome and dementia, and aged person. Glycoconjug J 17 (2000) 815-822
2. Nishi K., Tanegashima A., Yamamoto Y., Ushiyama I., Ikemoto K., Yamasaki S., et al. Utilization of lectin histochemistry in forensic neuropathology: lectin staining provides useful information for postmortem diagnosis in forensic neuropathology. Legal Med 5 (2003) 117-131
3. Toru M., Nishikawa T., Magata N., and Takashima N. Dopamine metabolism increases in post-mortem schizophrenic basal ganglia. J Neural Transm 54 (1982) 181-191
4. Olbrich H.M., Valerius G., Rüsch N., Buchert M., Thiel T., Hennig J., et al. Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study. World J Biol Psychiatry 9 (2008) 59-63
5. Raedler T.J., Knable M.B., and Weinberger D.R. Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol 8 (1998) 157-161
6. Lohr J.B., and Jeste D.V. Locus coeruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand 77 (1988) 689-697
7. Benes F.M., Todtenkopf M.S., and Taylor J.B. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 25 (1997) 80-92
8. Akil M., Pierri J.N., Whitehead R.E., Edgar C.L., Mohila C., Sampson A.R., et al. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry 156 (1999) 1580-1589
9. Akil M., Edgar C.L., Pierri J.N., Casali S., and Lewis D.A. Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects. Biol Psychiatry 47 (2000) 361-370
10. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57 (2000) 65-73
11. McGlashan T.H., and Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57 (2000) 637-648
12. Ikemoto K, Nishimura A, Nishi K, Oda T. Dopamine-related neuronal structures in post-mortem brains of schizophrenia - An immunohistochemical study. Dopamine 50 years, Gotegorg, Sweden, May 30-June 2, 2007, Abstracts; 2007. p. 104.
13. Ikemoto K, Niwa S. "New strategies for psychiatric research using post-mortem brains", Proceedings of the first symposium for brain bank, 22 October 2006, Fukushima, Japan. Psychiatry Clin Neurosci 2007;61:S19-23.
14. Nagatsu I., Kondo Y., Inagaki S., Krasawa N., Kato T., and Nagatu T. Immunofluorescent studies on tyrosine hydroxylase: application for its axoplasmatic transport. Acta Histochem Cytochem 10 (1977) 494-499
15. Ikemoto K., Satoh K., Kitahama K., and Maeda T. Demonstration of a new dopamine-containing cell group in the primate rostral telencephalon. Neurosci Lett 220 (1996) 1-3
16. Ikemoto K., Nagatsu I., Jouvet A., Nishimura A., Nishi K., Maeda T., et al. A dopamine-synthesizing cell group demonstrated in the human basal forebrain by dual labeling immunohistochemical technique of tyrosine hydroxylase and aromatic l-amino acid decarboxylase. Neurosci Lett 243 (1998) 129-132
17. Hokfelt T., Johansson O., and Goldstein M. Central catecholamine neurons as revealed by immunohistostochemistry with special reference to adrenaline neurons. In: Bjorklund A., and Hokfelt T. (Eds). Handbook of chemical neuroanatomy, vol. 2: classical transmitters in the CNS; Part 1 (1984), Elsevier 157-276
18. Pearson J., Goldstein M., Kitahama K., Sakamoto N., and Michel J.P. Catecholaminergic neurons of the human central nervous system. In: Riederer P., Kopp N., and Pearson J. (Eds). An introduction to neurotransmission in health and disease (1990), Oxford University Press, New York 22-36
19. Ikemoto K., Kitahama K., Jouvet A., Arai R., Nishimura A., Nishi K., et al. Demonstration of l-dopa decarboxylating neurons specific to human striatum. Neurosci Lett 232 (1997) 111-114
20. Berger B., Gaspar P., and Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 14 (1991) 21-27
21. Ikemoto K., Amano R., Ishibe A., Nishimura A., Nishi K., et al. Quantitative analysis of tyrosine hydroxylase, aromatic l-amino acid decarboxylase or phenylethanolamine-N-methyltransferase-immunoreactive neurons in the human medullary C1 region. Acta Histochem Cytochem 33 (2000) 259-265
22. Ikemoto K., Nishimura A., Okado N., Mikuni M., and Nagatsu I. Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration. Brain Res 853 (2000) 377-380
23. Kunii Y, Wada A, QiaoHui Y, Ikemoto K, Niwa S. DARPP-32 and calcineurin in post-mortem schizophrenic brains: an immunohistochemical study. Proceedings of the first symposium for brain bank, 22 October 2006, Fukushima Japan. Psychiatry Clin Neurisci 2007;61:S22-3.
24. Ikemoto K., Nishimura A., Oda T., Nagatsu I., and Nishi K. Number of striatal d-neurons is reduced in autopsy brains of schizophrenics. Legal Med 5 (2003) S221-S224
25. Maeda T., Ikemoto K., Satoh K., Kitahama K., and Geffard M. In: Segawa M., and Nomura Y. (Eds). Age-related dopamine-dependent disorders. Monographs in neural sciences 14, dopaminergic innervation of primate cerebral cortex: an immunohistochemical study in the macaque monkey (1995), Karger, Basel 147-159
26. Ikemoto K., Satoh K., Maeda T., and Fibiger H.C. Neurochemical heterogeneity of the primate nucleus accumbens. Exp Brain Res 104 (1995) 177-190
27. Ikemoto K., Kitahama K., Maeda T., and Satoh K. The distribution of noradrenaline, serotonin, and gamma-aminobutyric acid in the monkey nucleus accumbens. Prog Neuropsychopharmacol Biol Psychiatry 20 (1996) 1403-1412
28. Ikemoto K., Satoh K., Kitahama K., Geffard M., and Maeda T. Electron-microscopic study of dopaminergic structures in the medial subdivision of the monkey nucleus accumbens. Exp Brain Res 111 (1996) 41-50
29. Ikemoto K. Dopaminergic innervation in the monkey caudal nucleus accumbens. Brain Res Bull 43 (1997) 417-423
30. Ikemoto K., Nagatsu I., Nishimura A., Nishi K., and Arai R. Do all of the human midbrain tyrosine hydroxylase neurons synthesize dopamine?. Brain Res 805 (1998) 255-258
31. Kitahama K., Ikemoto K., Nagatsu I., Geffard M., Okamura H., and Pearson J. Aromatic l-amino acid decarboxylase and tyrosine hydroxylase immunohistochemistry in the adult human hypothalamus. J Chem Neuroanat 16 (1998) 43-55
32. Ikemoto K, Nishimura A, Nishi K, Amano R, Arai R, Nagatsu I. An immunohistochemical study of human monoamine neuronal systems using postmortem brains obtained by forensic autopsied cases. Rechtmedizin, 1999;A43(Suppl.).
33. Nagatsu I., Ikemoto K., Kitahama K., Nishimura A., Ichinose H., and Nagatsu T. Specific localization of the guanosine triphosphate (GTP) cyclohydrolase I-immunoreactivity in the human brain. J Neural Transm 106 (1999) 607-617
34. Ikemoto K., Kitahama K., Nishimura A., et al. Tyrosine hydroxylase and aromatic l-amino acid decarboxylase do not coexist in neurons in the human anterior cingulate cortex. Neurosci Lett 269 (1999) 37-40
35. Ikemoto K., Suzuki T., Ichinose H., Ohye T., Nishimura A., Nishi K., et al. Localization of sepiapterin reductase in the human brain. Brain Res 954 (2002) 237-246
36. Jaeger C.B., Teitelman G., Joh T.H., Albert V.R., Park D.H., and Reis D.J. Some neurons of rat central nervous system contain aromatic-l-amino-acid decarboxylase but not monoamines. Science 219 (1983) 1233-1235
37. Ikemoto K. Significance of human striatal d-neurons: implications in neuropsychiatric functions. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 429-434
38. Ikemoto K. Striatal d-neurons: in new viewpoints for neuropsychiatric research using post-mortem brains. Fukushima J Med Sci 54 (2008) 1-3
39. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11 (2006) 514-522
40. Duan X., Chang J.H., Ge S., Faulkner R.L., Kim J.Y., Kitabatake T., et al. Disrupted-in-schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 130 (2007) 1146-1158
41. Opgen-Rhein C., Neuhaus A.H., Urbanek C., Hahn E., Sander T., and Dettling M. Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test. Schizophr Bull (2008)
42. Tamura Y., Kunugi H., Ohshima J., and Hohjoh H. Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol Psychiatry 12 (2007) 593-600
43. Tsankova N., Renthal W., Kumar A., and Nestler E.J. Epigenetic modulation in psychiatric disorders. Nat Rev Neurosci 8 (2007) 355-367
44. Jin K., and Galvan V. Endogenous neural stem cells in the adult brain. J Neuroimmuno Pharmacol 2 (2007) 236-246
45. Rizos E.N., Papadopoulou A., Laskos E., Michalopoulou P.G., Kastania A., Vasilopoulos D., et al. Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry 10 (2008) 1-5
46. Niwa S. Constructing the Fukushima psychiatric brain bank. Proceedings of the first symposium for brain bank, 22 October 2006, Fukushima Japan. Psychiatry Clin Neurisci 2007;61:S19.
47. Ikemoto K. Comment on "Banking on the future of stem cells", Nature 452:263. Available from: http://www.nature.com/news/2008/080313/full/452263a.html [online].